Oxygen generation by combined electrolysis and fuel-cell technology: Clinical use in COPD patients requiring long time oxygen therapy

European Journal of Medical Research

Volumn 13, Issue 10, 2008, Pages 451-458

  Hirche, T O ^a   Born, T ^a   Jungblut, S ^a   Sczepanski, B ^b   Kenn, K ^b   Kohnlein T ^c   Hirche, H ^d   Wagner, Thomas O F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Hospital Berchtesgadener Land   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

COPD; Electrolysis; Fuel cell; LTOT; Oxygen; Saturation

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROLYSIS; FEASIBILITY STUDY; FEMALE; FLOW RATE; HUMAN; HYPOXEMIA; LONG TERM CARE; MALE; MULTICENTER STUDY; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN THERAPY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANOXIA; ELECTRIC POWER SUPPLIES; ELECTROLYSIS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; OXYGEN INHALATION THERAPY; PHYSICAL EXERTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REST; SLEEP;

EID: 56249115229     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-121.
2. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8:1398-1420.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555.
4. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93:391-398.
5. Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-686.
6. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med 2004; 98:285-293.
7. Borak J, Sliwinski P, Tobiasz M, Gorecka D, Zielinski J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis 1996; 51:7-11.
8. Clini E, Vitacca M, Foglio K, Simoni P, Ambrosino N. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 1996; 9:1605-1610.
9. Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J 2002; 20:38-42.
10. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 2005; 25:1032-1038.
11. Howard P, de Haller R. Domiciliary oxygen - by liquid or concentrator? Working Group on Oxygen Therapy of IUATLD. Eur Respir J 1991; 4:1284-1287.
12. Andersson A, Strom K, Brodin H, Alton M, Boman G, Jakobsson P, Lindberg A, Uddenfeldt M, Walter H, Levin LA. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J 1998; 12:1284-1289.
13. Tiep B. Portable oxygen therapy with oxygen conserving devices and methodologies. Monaldi Arch Chest Dis 1995; 50:51-57.
14. Tiep BL, Barnett J, Schiffman G, Sanchez O, Carter R. Maintaining oxygenation via demand oxygen delivery during rest and exercise. Respir Care 2002; 47:887-892.
15. Ringbaek TJ. Continuous oxygen therapy for hypoxic pulmonary disease: guidelines, compliance and effects. Treat Respir Med 2005; 4:397-408.
16. Dunne PJ. The demographics and economics of long-term oxygen therapy. Respir Care 2000; 45:223-228.
17. Neri M, Melani AS, Miorelli AM, Zanchetta D, Bertocco E, Cinti C, Canessa PA, Sestini P. Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian Study on Oxygen Therapy Adherence (MISOTA). Respir Med 2006; 100:795-806.
18. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006; 174:373-378.
19. Rosner B. Fundmentals of biostatistics. 5th edition. Duxberry Thompson Learning, Pacific Grove, CA, 2000.
20. Levitzky MG. Pulmonary physiology. 7th edition, McGraw-Hill Medical, Hightstown, New Jersey, 2007.
21. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:892-898.
22. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP, III, Martinez FJ. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168:1084-1090.
23. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet 1981; 1:907-909.
24. Bye PT, Esau SA, Levy RD, Shiner RJ, Macklem PT, Martin JG, Pardy RL. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am Rev Respir Dis 1985; 132:236-240.
25. Douglas NJ, Calverley PM, Leggett RJ, Brash HM, Flenley DC, Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1979; 1:1-4.
26. Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76:536-542.
27. Fletcher EC, Levin DC. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen. Chest 1984; 85:6-14.
28. 2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 1992; 101:649-655.
29. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med 2006; 174:373-378.
30. Bower JS, Brook CJ, Zimmer K, Davis D. Performance of a demand oxygen saver system during rest, exercise, and sleep in hypoxemic patients. Chest 1988; 94:77-80.
31. Howard P, de Haller R. Domiciliary oxygen - by liquid or concentrator? Working Group on Oxygen Therapy of IUATLD. Eur Respir J 1991; 4:1284-1287.
32. Schaanning J, Strom K, Boe J. Do patients using long-term liquid oxygen differ from those on traditional treatment with oxygen concentrators and/ or compressed gas cylinders? A comparison of two national registers. Respir Med 1998; 92:84-87.
33. Reisfield GM, Wilson GR. The cost of breathing: an economic analysis of the patient cost of home oxygen therapy. Am J Hosp Palliat Care 2004; 21:348-352.
34. Kampelmacher MJ, van Kestern RG, Alsbach GP, Melissant CF, Wynne HJ, Douze JM, Lammers JW. Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands. Respir Med 1998; 92:70-75.
35. Johns DP, Rochford PD, Streeton JA. Evaluation of six oxygen concentrators. Thorax 1985; 40:806-810.
36. Gallegos LC, Shigeoka JW. Novel oxygen-concentrator-based equipment: take a test drive first! Respir Care 2006; 51:25-28.
37. Katsenos S, Charisis A, Daskalopoulos G, Constantopoulos SH, Vassiliou MP. Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece. Respiration 2006; 73:777-782.
38. Andersson A, Strom K, Brodin H, Alton M, Boman G, Jakobsson P, Lindberg A, Uddenfeldt M, Walter H, Levin LA. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J 1998; 12:1284-1289.
39. McDonald CF, Crockett AJ, Young IH. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust 2005; 182:621-626.
40. Cahill Lambert AE. Adult domiciliary oxygen therapy: a patient's perspective. Med J Aust 2005; 183:472-473.
41. Andersen I, Lundqvist GR, Jensen PL, Proctor DF. Human response to 78-hour exposure to dry air. Arch Environ Health 1974; 29:319-324.
42. Proctor DF, Andersen I, Lundqvist GR. Human nasal mucosal function at controlled temperatures. Respir Physiol 1977; 30:109-124.
43. Williams R, Rankin N, Smith T, Galler D, Seakins P. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med 1996; 24:1920-1929.
44. Sheppard D, Eschenbacher WL, Boushey HA, Bethel RA. Magnitude of the interaction between the bronchomotor effects of sulfur dioxide and those of dry (cold) air. Am Rev Respir Dis 1984; 130:52-55.
45. Rankin N. What is optimum humidity? Respir Care Clin N Am 1998; 4:321-328.
46. Waugh JB, Granger WM. An evaluation of 2 new devices for nasal high-flow gas therapy. Respir Care 2004; 49:902-906.
47. Cameron JL, Reese WA, Tayal VS, Clark RF, Kelso D, Gonzalez ER, Garnett AR, Ornato JP. Bacterial contamination of ambulance oxygen humidifier water reservoirs: a potential source of pulmonary infection. Ann Emerg Med 1986; 15:1300-1302.
48. Pendleton N, Cheesbrough JS, Walshaw MJ, Hind CR. Bacterial colonisation of humidifier attachments on oxygen concentrators prescribed for long term oxygen therapy: a district review. Thorax 1991; 46:257-258.
49. Rhame FS, Streifel A, McComb C, Boyle M. Bubbling humidifiers produce microaerosols which can carry bacteria. Infect Control 1986; 7:403-407.